157 related articles for article (PubMed ID: 37743057)
1. Predictive factors of surgical complications after pelvic exenteration for gynecological malignancies: a large single-institution experience.
Tortorella L; Marco C; Loverro M; Carmine C; Persichetti E; Bizzarri N; Barbara C; Francesco S; Foschi N; Gallotta V; Avesani G; Chiantera V; Ercoli A; Fanfani F; Fagotti A; Mele MC; Restaino S; Gueli Alletti S; Scambia G; Vizzielli G
J Gynecol Oncol; 2024 Jan; 35(1):e4. PubMed ID: 37743057
[TBL] [Abstract][Full Text] [Related]
2. Prediction of short-term surgical complications in women undergoing pelvic exenteration for gynecological malignancies.
Tortorella L; Casarin J; Mara KC; Weaver AL; Multinu F; Glaser GE; Cliby WA; Scambia G; Mariani A; Kumar A
Gynecol Oncol; 2019 Jan; 152(1):151-156. PubMed ID: 30414740
[TBL] [Abstract][Full Text] [Related]
3. Major complications following exenteration in cases of pelvic malignancy: a 10-year experience.
Wydra D; Emerich J; Sawicki S; Ciach K; Marciniak A
World J Gastroenterol; 2006 Feb; 12(7):1115-9. PubMed ID: 16534855
[TBL] [Abstract][Full Text] [Related]
4. Comparison of postoperative complications and quality of life between patients undergoing continent versus non-continent urinary diversion after pelvic exenteration for gynecologic malignancies.
Angeles MA; Mallet E; Rouanet P; Cabarrou B; Méeus P; Lambaudie E; Foucher F; Narducci F; Loaec C; Gouy S; Guyon F; Marchal F; Gladieff L; Martínez-Gómez C; Migliorelli F; Martinez A; Ferron G
Int J Gynecol Cancer; 2020 Feb; 30(2):233-240. PubMed ID: 31796531
[TBL] [Abstract][Full Text] [Related]
5. Pelvic exenteration for recurrent or persistent gynecologic malignancies: Clinical and histopathologic factors predicting recurrence and survival in a modern cohort.
Straubhar AM; Chi AJ; Zhou QC; Iasonos A; Filippova OT; Leitao MM; Awowole IO; Abu-Rustum NR; Broach VA; Jewell EL; Sandhu JS; Sonoda Y
Gynecol Oncol; 2021 Nov; 163(2):294-298. PubMed ID: 34518053
[TBL] [Abstract][Full Text] [Related]
6. Pelvic exenteration for recurrent gynecologic malignancy: a study of 28 consecutive patients at a single institution.
Jäger L; Nilsson PJ; Rådestad AF
Int J Gynecol Cancer; 2013 May; 23(4):755-62. PubMed ID: 23407096
[TBL] [Abstract][Full Text] [Related]
7. Factors Predictive of 90-Day Morbidity, Readmission, and Costs in Patients Undergoing Pelvic Exenteration.
Bogani G; Signorelli M; Ditto A; Martinelli F; Casarin J; Mosca L; Leone Roberti Maggiore U; Chiappa V; Lorusso D; Raspagliesi F
Int J Gynecol Cancer; 2018 Jun; 28(5):975-982. PubMed ID: 29683876
[TBL] [Abstract][Full Text] [Related]
8. Pelvic exenteration for gynecologic malignancies: The experience of a tertiary center from Greece.
Haidopoulos D; Pergialiotis V; Aggelou K; Thomakos N; Alexakis N; Stamatakis E; Rodolakis A
Surg Oncol; 2022 Mar; 40():101702. PubMed ID: 35065392
[TBL] [Abstract][Full Text] [Related]
9. Pelvic exenteration for gynecologic malignancies: Postoperative complications and oncologic outcomes.
Romeo A; Gonzalez MI; Jaunarena J; Zubieta ME; Favre G; Tejerizo JC
Actas Urol Esp (Engl Ed); 2018 Mar; 42(2):121-125. PubMed ID: 28911880
[TBL] [Abstract][Full Text] [Related]
10. Pelvic exenteration: ten-year experience at the European Institute of Oncology in Milan.
Maggioni A; Roviglione G; Landoni F; Zanagnolo V; Peiretti M; Colombo N; Bocciolone L; Biffi R; Minig L; Morrow CP
Gynecol Oncol; 2009 Jul; 114(1):64-8. PubMed ID: 19411097
[TBL] [Abstract][Full Text] [Related]
11. Pelvic exenteration for recurrent gynecologic malignancy: survival and morbidity analysis of the 45-year experience at UCLA.
Berek JS; Howe C; Lagasse LD; Hacker NF
Gynecol Oncol; 2005 Oct; 99(1):153-9. PubMed ID: 16054678
[TBL] [Abstract][Full Text] [Related]
12. A modern-day experience with Brunschwig's operation: Outcomes associated with pelvic exenteration.
Rios-Doria E; Filippova OT; Straubhar AM; Chi A; Awowole I; Sandhu J; Broach V; Mueller JJ; Gardner GJ; Jewell EL; Zivanovic O; Leitao MM; Long Roche K; Abu-Rustum NR; Sonoda Y
Gynecol Oncol; 2022 Nov; 167(2):277-282. PubMed ID: 36064678
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes of pelvic exenterations for gynecological malignancies: a single-center retrospective cohort study.
Yu JH; Tong CJ; Huang QD; Ye YL; Chen G; Li H; Wen YS; Yang F; Luo NB; Xu GY; Xiong Y
BMC Cancer; 2024 Jan; 24(1):88. PubMed ID: 38229045
[TBL] [Abstract][Full Text] [Related]
14. Pelvic exenteration for vulvar cancer: Postoperative morbidity and oncologic outcome - A single center retrospective analysis.
Valstad H; Eyjolfsdottir B; Wang Y; Kristensen GB; Skeie-Jensen T; Lindemann K
Eur J Surg Oncol; 2023 Sep; 49(9):106958. PubMed ID: 37349160
[TBL] [Abstract][Full Text] [Related]
15. Surgical results of pelvic exenteration in the treatment of gynecologic cancer.
Petruzziello A; Kondo W; Hatschback SB; Guerreiro JA; Filho FP; Vendrame C; Luz M; Ribeiro R
World J Surg Oncol; 2014 Sep; 12():279. PubMed ID: 25200866
[TBL] [Abstract][Full Text] [Related]
16. Pelvic exenteration for gynecological malignancies: an analysis of 15 cases operated on at a single institution.
Mäenpää JU; Kangasniemi K; Luukkaala T
Acta Obstet Gynecol Scand; 2010; 89(2):279-83. PubMed ID: 19916881
[TBL] [Abstract][Full Text] [Related]
17. [Observational study on perioperative outcomes of pelvic exenteration].
Yuan H; Yao B; Li JT; Zhu WL; Ren DL; Wang H; Ma TH; Chen SQ; Wu JJ; Tao YR; Ye L; Wang ZY; Qu H; Ma B; Zhong WW; Wang DJ; Qiu JG
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Mar; 26(3):260-267. PubMed ID: 36925126
[No Abstract] [Full Text] [Related]
18. Incidence and management of major urinary complications after pelvic exenteration for gynecological malignancies.
Bladou F; Houvenaeghel G; Delpéro JR; Guérinel G
J Surg Oncol; 1995 Feb; 58(2):91-6. PubMed ID: 7844989
[TBL] [Abstract][Full Text] [Related]
19. Major complications of urinary diversion after pelvic exenteration for gynecologic malignancies: a 23-year mono-institutional experience in 124 patients.
Houvenaeghel G; Moutardier V; Karsenty G; Bladou F; Lelong B; Buttarelli M; Delpero JR
Gynecol Oncol; 2004 Feb; 92(2):680-3. PubMed ID: 14766266
[TBL] [Abstract][Full Text] [Related]
20. Pelvic exenterations for gynecological malignancies: a study of 36 cases.
Kaur M; Joniau S; D'Hoore A; Van Calster B; Van Limbergen E; Leunen K; Penninckx F; Van Poppel H; Amant F; Vergote I
Int J Gynecol Cancer; 2012 Jun; 22(5):889-96. PubMed ID: 22617477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
